# Observation of Treatment Patterns With Lucentis® in Real-life Conditions in All Approved Indications

> **NCT04847895** · — · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 5500 (actual)

## Conditions studied

- Neovascular (Wet) Age-related Macular Degeneration

## Interventions

- **DRUG:** Lucentis

## Key facts

- **NCT ID:** NCT04847895
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06-01
- **Primary completion:** 2021-03-31
- **Final completion:** 2021-03-31
- **Target enrollment:** 5500 (ACTUAL)
- **Last updated:** 2021-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04847895

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04847895, "Observation of Treatment Patterns With Lucentis® in Real-life Conditions in All Approved Indications". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04847895. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*